BioMarin Pharmaceutical News

BioMarin Pharmaceutical Inc. said Tuesday it opened a new office in Brisbane to expand drug development operations.

NOVATO, Calif., Sept. 18 CA-BioMarin-Corrects NOVATO, Calif. , /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

The recently renovated 18-hole Marin Country Club is the site of the Novato Chamber of Commerce 8th annual Fall Classic Golf Tournament, slated for Monday, Oct.

Sept. 12, 2008 - William Blair & Company initiated research coverage of BioMarin Pharmaceutical Inc.

The U.S. Environmental Protection Agency has fined BioMarin Pharmaceutical $119,717 after its Novato, Calif., facility violated the Clean Water Act on numerous occasions by discharging low pH industrial ...

Conference calls scheduled at 10 to 10:30 a.m. on Investrend Broadcast via partner BestCalls include Hi-Tech Pharmacal Co.

The registry is open to all PKU clinics within the United States, and all patients screened for Kuvan responsiveness are eligible for enrollment in the registry.

After years of losses, BioMarin Pharmaceutical made the leap to profitability and announced banner second-quarter net product revenues.

Raptor Pharmaceuticals Corp. has a strategy to soar above the challenges to small, preclinical drug developers, namely funding.

Philip Nadeau - Cowen & Co. Thomas McGahren - Merrill Lynch Vernon Bernardino - Rodman & Renshaw Andrew Vaino - Roth Capital Lucy Lou - Citigroup Presentation Operator Good day ladies and gentlemen and welcome ...

A group of former BioMarin Pharmaceutical executives -- including a cofounder of the Novato company -- are using a familiar formula to push forward with Raptor Pharmaceuticals Corp.

Novato Chamber of Commerce CEO Coy Smith Novato-based BioMarin Pharmaceutical Inc.

Biotech Firm Summit Corporation in 70 Million Deal with BioMarin Pharmaceutical Inc.

Biotech Firm Summit Corporation in 70 Million Deal with BioMarin Pharmaceutical Inc.

MOST NOTEWORTHY: Solarfun Power, BioMarin Pharmaceutical and Genentech were today's noteworthy initiations: Jefferies initiated Solarfun Powe r with a Buy rating and $18 target.

BioMarin Pharmaceutical Inc. announced today that Asubio Pharma Co., Ltd. , has received marketing approval from the Japanese Ministry of Health, Labour and Welfare for a label extension of Biopten , which ...

BioMarin Pharmaceutical Inc. is having a good year. Sales of its three approved drugs are on the rise.

Cary, N.C. &#8212 June 26, 2008 &#8212 BioMarin Pharmaceutical Inc. , a biopharmaceutical research and development firm, has chosen the SciQuest e-procurement platform to streamline and enhance procurement ...

A Citi Investment Research analyst said Thursday that BioMarin Pharmaceutical Inc.'s drug Kuvan may not become as popular as Wall Street expects, and she downgraded the shares to "Hold" from "Buy." After ...

BioMarin Pharmaceutical Inc. recently announced its program for its third enzyme replacement therapy for the treatment of mucopolysaccharidosis IVA , or Morquio A Syndrome.